Literature DB >> 14107743

INTERNATIONAL STANDARDS FOR ANTI-POLIOVIRUS SERA TYPES 1, 2 AND 3.

J LYNG, M W BENTZON.   

Abstract

Anti-poliovirus sera types 1, 2 and 3 were examined in an international collaborative study to test their suitability as international standards. It was concluded that the sera are suitable for the purpose, and they are accordingly established as International Standards for Anti-Poliovirus Sera, Types 1, 2 and 3, replacing the existing International Reference Preparations for the same sera, established in 1958.The unitage was defined as follows:For Type 1 preparation: 1 unit is 10.78 mg.For Type 2 preparation: 1 unit is 10.46 mg.For Type 3 preparation: 1 unit is 10.48 mg.

Entities:  

Keywords:  BIOLOGICAL ASSAY; CHEMISTRY, PHARMACEUTICAL; IMMUNE SERUMS; POLIOVIRUS VACCINE, ORAL

Mesh:

Substances:

Year:  1963        PMID: 14107743      PMCID: PMC2555101     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  An international collaborative study of the assay of the potency of poliomyelitis sera.

Authors:  M W BENTZON; D G EVANS; O MAALOE; F T PERKINS; J SPAUN
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

2.  British standard poliomyelitis antisera types 1, 2, and 3.

Authors:  F T PERKINS; D G EVANS
Journal:  Br Med J       Date:  1959-06-20

3.  The use of guinea pigs in tests for immunogenic capacity of poliomyelitis virus preparations.

Authors:  S GARD; T WESSLEN; A FAGRAEUS; A SVEDMYR; G OLIN
Journal:  Arch Gesamte Virusforsch       Date:  1956

4.  Biological standardization of typhoid vaccines by antibody measurements.

Authors:  J SPAUN
Journal:  Acta Pathol Microbiol Scand       Date:  1956

5.  Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissue-culture system.

Authors:  J E SALK; J S YOUNGNER; E N WARD
Journal:  Am J Hyg       Date:  1954-09
  5 in total
  2 in total

1.  Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

2.  A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine.

Authors:  J L Henry; E S Jaikaran; J R Davies; A J Tomlinson; P J Mason; J M Barnes; A J Beale
Journal:  J Hyg (Lond)       Date:  1966-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.